MedPath

Evaluation of the Impact of neuromodulators on urinary, intestinal and sexual functions and on spasticity in spinal cord injured individuals

Not Applicable
Conditions
Thoracic traumatic spinal cord injury, sequelae of injury of spinal cord
T91.3
Registration Number
RBR-4w6v2c
Lead Sponsor
Hospital São Paulo - Hospital Universitário da Universidade Federal de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Individuals aging 18 to 60 years, with partial or complete spinal cord injury ASIA (American Spinal Injury Association) score A or B, in clean intermitent self-catheterization and/or with urinary incontinence and neurologically stable for more than one year.

Exclusion Criteria

Subjects with the following characteristics will be excluded: urodynamic bladder atonia; suspicion of vesicoureteral reflux prior to the spinal cord injury;Diabetes Mellitus, compensated or not;congenital or acquired immunodeficiency; known or suspected malignancy; history of rectossigmoidectomy, colectomy, or other gastrointestinal surgeries that can cause changes in bowel habits, stool anal continence or function; history of surgical treatment of uterovaginal prolapse, urinary incontinence, bladder augmentation procedures or other procedures associated with dysfunctional voiding (urethrotomy etc.); history of prostatectomy, transurethral resection of the prostate or prostatic other invasive procedures except biopsy; history of central or peripheral procedures neuroablative as rizotomy, cordotomy etc.;uterovaginal prolapse, rectal or urethral;cystostomy; anal or urethral stenosis.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase on maximum cystometric capacity and bladder compliance as assessed by urodynamic study; increase on voided volume and decrease on the number of incontinence episodes and need for bladder catheterization; improvement of quality of life related to bladder function, as assessed by the Qualiveen questionnaire; improvement in spasticity as assessed by the SCATS system (Spinal Cord Assessment Tool for Spastic Reflexes)
Secondary Outcome Measures
NameTimeMethod
Increased rectal sensitivity and capacity evaluated by intrarretal balloon; improvement of pelvic floor muscle function measured by digital palpation and intracavitary electromyography; improved sexual function in men evaluated by International Index of Erectile Function questionnaire, and in women at the Female Sexual Function Index questionnaire; histological changes of the femoral rectus muscles by biopsy; increased active range of motion of the lower limbs and trunk measured by goniometry; changes in patterns of gait and balance evaluated by Barthel scale; improvement in overall sleep quality assessed by the Pittsburgh questionnaire validated Brazilian Portuguese and also of daytime sleepiness measured by the Epworth questionnaire validated for the Brazilian Portuguese; improved body image assessed by testing the Human Figure Drawing.
© Copyright 2025. All Rights Reserved by MedPath